by CEO, Yury Gampel

Historically, inpatient and outpatient models of healthcare have not been friendly to each other. Proponents of outpatient care accuse hospitals of being too expensive and inefficient: a façade that too often hides inadequately trained employees and outdated treatment methods. Proponents of inpatient care argue that outpatient facilities are “procedure mills” that do not adequately emphasize non-procedural and non-surgical alternatives.

At Modern Vascular, we believe that the health of our patients is foundational. Our business model is built to incorporate the best aspects of both models of healthcare to improve patient experience and clinical outcomes. We see that financial success does not result from cutting corners; it comes only as a result of sustained investment into quality of care.

This is reflected in our operational design. We do not run a “procedure mill” but instead choose the most appropriate treatment plans for our patients. For example, a procedure would not be recommended to a patient who has PAD but is entirely asymptomatic. Similarly, we do not recommend a procedure to a symptomatic patient whose disease has not progressed far enough to warrant procedural intervention and may be managed through exercise and/or medications. Overall, more than half of our patients are recommended lifestyle changes, monitoring symptoms, and other non-invasive treatments. We reserve our procedure room time and resources only for those cases in which the benefit to the patient outweighs the risks of procedural intervention.

This a win-win approach. Neither Modern Vascular nor our patients spend unnecessary money or time. Neither Modern Vascular nor our patients take unnecessary risks. After all, even a minimally invasive procedure presents a possibility of complications. More importantly, our approach further proves that the best practices in health care also produce the best operational outcomes.

Modern Vascular Newsletter Cover

Leading a Patient-Centric Outpatient Organization

Quarterly Newsletter, Fall 2020, Vol. 10

This quarter’s newsletter features a short article from the CEO of Modern Vascular, Yury Gampel. Also, Modern Vascular is proud to announce that they are the recipient of Global Health & Pharma’s “Best Peripheral Artery Disease Treatment Specialists” award for the year of 2020. It also discuss the pilot plan in Fort Worth where CRNA’s provide anesthesia care for Modern Vascular’s patients.

Download the PDF

Modern Vascular Recognized as Best PAD Treatment Specialist in the USA

Global Health and Pharmaceuticals has announced its Best In Healthcare awards for 2020 and Modern Vascular is proud to be on the list.

“Modern Vascular is employing a new approach to the treatment of Peripheral Artery Disease (PAD) and, in only 3 years, has helped thousands of patients maintain their lifestyle and avoid lower leg amputations. Modern Vascular brings new hope to PAD patients across the US through its use of cutting-edge technology and minimally invasive outpatient procedures and this is why they are being recognized in this year’s Global Healthcare and Pharmaceutical Awards.”

Read more about the award

“I have no words to say how amazing this facility is and how attentive the doctors are. Dr. Broadway saved my mother’s leg from being amputated 1 day prior to her amputation surgery. My mother’s prior doctor gave her two choices either amputation or live with the pain so amputation was her option. Her doctor stated she had poor circulation and no blood fl ow. A great friend recommended Dr. Broadway and he gave her the third choice which was to keep her leg… Today, my mother still has her leg because of the great doctors at Modern Vascular.”

Judith , San Antonio

Modern Vascular Piloting Use of Nurse Anesthetists in Texas

Starting October 2020, Modern Vascular of Fort Worth will use Certified Registered Nurse Anesthetists (CRNAs) to provide anesthesia care to our patients. We received the feedback from referring providers that their patients reported that their pain was not optimally controlled during and after their procedures. After listening to the feedback, Modern Vascular committed to improving the patient experience and brought CRNA’s into the facilities to better control patients pain levels during and after their procedure.

The use of CRNAs allows Modern Vascular to use certain type of sedatives to achieve better pain control. We started this model a few months ago in our San Antonio offices and patients already report that their experience is much improved and they experience very little pain during and after the procedure. We were excited to extend this service to the Fort Worth office and improve the patient experience starting in October. If we see continued success, we will be looking to expand this new clinical pain management model to additional markets by the end of the year.

Read the full PDF newsletter